A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/675 (2006.01) A61J 3/06 (2006.01) A61K 9/20 (2006.01)
Patent
CA 2528191
A pyridoxal-5'-phosphate pharmaceutical formulation suitable for oral administration is provided comprising a dissolution profile, when measured in a standard dissolution apparatus, according to the United States Pharmacopoeia dissolution test, at 37°C in a 0.05M phosphate buffered solution having a pH of 6.8 at 75 rpm, as follows: (a) greater than about 30% at 15 minutes, (b) greater than about 85% at 30 minutes, (c), greater than about 90% at 45 minutes, or (d) greater than about 95% at 60 minutes. Additionally, in vivo oral intake of between 15 and 60 mg/kg of a pyridoxal-5'-phosphate pharmaceutical formulation can produce a maximum plasma level (C max) of between about 1 mg/L and 8 mg/L. The pharmaceutical formulation provided comprises (a) a core, wherein said core comprises pyridoxal-5'-phosphate or a pharmaceutically acceptable salt thereof; (b) a sub-coat surrounding the core; and (c) an enteric coat surrounding the sub-coat.
Carter John
Friesen Albert
Medicure International Inc.
Ridout & Maybee Llp
LandOfFree
Novel formulation of pyridoxal 5'-phosphate and method of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel formulation of pyridoxal 5'-phosphate and method of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel formulation of pyridoxal 5'-phosphate and method of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1755037